Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1998The LancetOpen Access

Trial of oral miltefosine for visceral leishmaniasis

View Full Paper
Ask AI
Bookmark
Share

Authors

SSShyam SundarNIMS UniversityFRF. RosenkaimerBoehringer Ingelheim (Egypt)MMM K MakhariaRoyal Free London NHS Foundation Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sundar et al. (1998) studied this question.

synapsesocial.com/papers/69d9a0e89a6164e50fa3d225https://doi.org/10.1016/s0140-6736(98)04367-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer Patients2009 · 15 citations
  2. 2Distribution and metabolism of hexadecylphosphocholine in mice1987 · 78 citations
  3. 3Short-Course, Low-Dose Amphotericin B Lipid Complex Therapy for Visceral Leishmaniasis Unresponsive to Antimony1997 · 103 citations
  4. 4Phase 2 Efficacy Trial of an Oral 8-Aminoquinoline (WR6026) for Treatment of Visceral Leishmaniasis1994 · 91 citations